Find a Supplier
ADD YOUR COMPANY
Cellumed and ARTES Sign Development and License Agreement
Contact Us Subscribe to Newsletter
Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    Cellumed and ARTES Sign Development and License Agreement

    ARTES Biotechnology GmbH News Releases

    Find the latest News from ARTES Biotechnology GmbH

    Page 2 of 4
    Cellumed and ARTES Sign Development and License Agreement
    Cellumed and ARTES Sign Development and License Agreement

    Thursday 14th October 2021

    By  ARTES Biotechnology… Learn More >
    “Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations
    “Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations

    Thursday 14th January 2021

    By  ARTES Biotechnology… Learn More >
    ARTES is convinced: defeating SARS COVID-19 will require different vaccines
    ARTES is convinced: defeating SARS COVID-19 will require different vaccines

    Friday 11th September 2020

    By  ARTES Biotechnology… Learn More >
    Worldwide, researchers work on a coronavirus vaccine
    Worldwide, researchers work on a coronavirus vaccine

    Tuesday 16th June 2020

    By  ARTES Biotechnology… Learn More >
    ARTES joins global CV-19 combat with VLP vaccine candidates
    ARTES joins global CV-19 combat with VLP vaccine candidates

    Monday 27th April 2020

    By  ARTES Biotechnology… Learn More >
    France renews CIR tax credits for ARTES R&D services
    France renews CIR tax credits for ARTES R&D services

    Thursday 2nd April 2020

    By  ARTES Biotechnology… Learn More >
    ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris
    ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris

    Monday 9th March 2020

    By  ARTES Biotechnology… Learn More >
    Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute
    Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute

    Friday 13th September 2019

    By  ARTES Biotechnology… Learn More >
    ARTES presenting new development offer at BIOEurope Spring in Vienna
    ARTES presenting new development offer at BIOEurope Spring in Vienna

    Tuesday 12th March 2019

    By  ARTES Biotechnology… Learn More >
    ARTES adds SplitCore technology to vaccine development portfolio
    ARTES adds SplitCore technology to vaccine development portfolio

    Monday 7th January 2019

    By  ARTES Biotechnology… Learn More >
    ARTES and Minapharm join forces to package biopharma solutions
    ARTES and Minapharm join forces to package biopharma solutions

    Monday 10th September 2018

    By  ARTES Biotechnology… Learn More >
    ARTES successfully completes EU-funded project PLURIVAX
    ARTES successfully completes EU-funded project PLURIVAX

    Wednesday 18th April 2018

    By  ARTES Biotechnology… Learn More >
    Page 2 of 4
    Full Supplier Profile